Spyre Therapeutics, Inc. - COM NEW (SYRE)

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
50.4M
Holdings value Q2 2024
$1.18B
Value change Q2 2024
+$422M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
106
Number of buys Q2 2024
73
Number of sells Q2 2024
-39
Average buys Q2 2024 %
+0.002%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 12.6K $370K +$207K $29.39 1
2024 Q2 50.4M $1.18B +$422M $23.51 106
2024 Q1 31.6M $1.2B +$173M $37.93 101
2023 Q4 28M $601M +$524M $21.52 54
2023 Q3 3.26M $39.9M +$39.9M $12.25 27